<DOC>
	<DOCNO>NCT00991302</DOCNO>
	<brief_summary>Adherence highly active antiretroviral therapy ( HAART ) critical successful treatment HIV . This study test intervention help people infected HIV take medication suppose .</brief_summary>
	<brief_title>Durability Adherence Self-Management HIV</brief_title>
	<detailed_description>People infect HIV must take regimen highly active antiretroviral therapy ( HAART ) medication prescribe , without miss dos , risk develop resistant strain virus . Resistant strain virus respond certain HAART regimens dangerous patient . Poor HAART adherence lead HIV progression , hospitalization opportunistic infection , require use second-line therapy . Interventions increase adherence mixed success , little data support long-term effect one strategy emerge provide consistent positive effect . The client adherence profile intervention tailoring ( CAP-IT ) program first develop increase adherence among people already HAART in-home nursing . This study modify CAP-IT treat people newly HAART test whether modify CAP-IT improved long-term HAART adherence . This study include two stage . The first stage consist two focus group , one make HIV care provider professional make people infected HIV start HAART within last year . Each focus group meet , approximately 2 hour , determine modification would best adapt CAP-IT program HIV-infected people first start HAART . The second stage consist randomized trial compare modified CAP-IT program standard care . Participation stage last 72 week . Participants randomly assign receive either standard care modify CAP-IT program addition standard care . The CAP-IT program involve two step . The first assessment factor relate adherence , second development individualize plan address deficit find . Study visit complete entry , Weeks 4 12 , every 12 week approximately 72 week . Assessments study include questionnaire health attitude , physical exam , count pill , answer question take medication .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<criteria>Stage 1 HIV infected Individuals Highly Active Antiretroviral Therapy ( HAART ) : HIV1 infection Initiated HAART within 1 year prior study entry remain HAART least 30 consecutive day Men woman hade reached legal age majority country enrol Ability willingness provide inform consent Willingness discuss personal topic audiotaped group interview Willingness protect confidentiality focus group participants Health Care Providers Professionals : Healthcare provider professional ( e.g. , medical doctor [ MDs ] , nurse practitioner [ NPs ] , physician assistant [ PAs ] , adherence counselor ) recruit outside local clinical research site ( CRS ) whose patient population include majority HIV1 seropositive patient recent experience manage ARTnaive individual start HAART Men woman reach legal age majority country enrol Willingness discuss personal topic audiotaped group interview Willingness protect confidentiality focus group participant proceed Stage 2 : HIV1 infection Antiretroviral ( ARV ) treatment naive , plan initiate HAART within 7 day study entry either context approve parent AIDS Clinical Trial Group ( ACTG ) clinical trial context primary HIV care University California , San Diego ( UCSD ) , USA Asociacion Civil Impacta Salud Y Educaci ( IMPACTA ) , Peru , CRSaffiliated site HIV1 RNA great 1,000 copies/mL obtain within 90 day prior study entry laboratory clinical laboratory improvement amendment ( CLIA ) certification equivalent CD4+/CD8+ count obtain within 90 day prior study entry laboratory CLIA certification equivalent Men woman reach legal age majority country enrol Ability follow instruction complete survey questionnaires minimal assistance Stage 1 HIV1 Infected Individuals HAART : Failure remain HAART least 30 consecutive day Diminished cognitive capacity , opinion screen CRS clinician , would interfere study participation Participation prior focus group study A5250 Health Care Providers Professionals : Health care provider professional would involve administer standard care ( SOC ) treatment adherence counseling Stage 2 participant randomize SOC arm CRS investigator health care provider professional directly involve measure adherence outcome Stage 2 Participation prior focus group study A5250 Stage 2 : Potential participant , judgment research team , unable complete protocol Potential participant start NNRTIbased regimen within 12 month receive singledose NVP pregnancy prevent MTCT HIV Potential participant partner close contact participant enrol Stage 2 Potential participant currently enrol ACTG protocol utilize test adherence intervention</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Adherence</keyword>
	<keyword>Behavioral Intervention</keyword>
	<keyword>Antiretroviral Therapy</keyword>
	<keyword>ART</keyword>
	<keyword>Highly Active Antiretroviral Therapy</keyword>
	<keyword>HAART</keyword>
	<keyword>Treatment experience</keyword>
</DOC>